Resources

ROI Analysis of the Tumor Management System

November 21, 2022

ROI Analysis of the Tumor Management System

Cem Girit1
Biopticon Corporation, Plainsboro, NJ 08536. Corresponding author. Email:girit@biopticon.com

Abstract

The Tumor Management System consists of the TumorImagerTM, used for rapidly and noninvasively imaging subcutaneous tumors on un-anesthetized mice used in preclinical oncology studies, and TumorManagerTM, a comprehensive study management program that integrates seamlessly with the TumorImagerTM system and other devices (including calipers) for managing all aspects of a study from protocol creation, data acquisition and analysis, to final reports.

Read Full Article